Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Could Gilead face early Sovaldi generics in Europe?

EU patent protection for the hepatitis C virus drug will end in 2024

- PMLiVE

Quanticate names chief operating officer

Alan Morgan joins the data-focused clinical research organisation

- PMLiVE

Nanobiotix strengthens US leadership team

Dr Mihail Obrocea and Noël Kurdi join the nanomedicine company

- PMLiVE

Driving adoption of Commercial Analytic solutions

Measuring campaign success is key for pharma and the rise of multichannel campaigns has brought with it an increase in spending on commercial analytic solutions, which help users identify opportunities...

- PMLiVE

IPA reveals 2016 Best of Health Show shortlist

33 agencies in with a chance to win at the healthcare advertising awards

- PMLiVE

Alnylam pulls lead drug revusiran after deaths in phase III trial

US biotech has yet to determine the cause of the amyloidosis and cardiomyopathy study fatalities

- PMLiVE

Regional NHS pulmonary rehabilitation video campaign launched

Aims to boost referral rates among GPs in the north east of England

- PMLiVE

UCB launches UK product helpline for patients and HCPs

UCBCares will answer treatment queries and use feedback to drive innovation

- PMLiVE

Teva sells UK and Ireland assets to Intas Pharma for £603m

Generics portfolio and manufacturing facility gain set to double Indian firm’s UK sales

- PMLiVE

Cytovation expands management team

Raj Airey and Federico Grego join the Norwegian biotech

- PMLiVE

Ashfield Meetings & Events appoints board member

Laura Brown becomes senior vice president of operations

Roche Basel Switzerland

Roche snags pair of FDA breakthrough designations

Accelerates approval process for NSCLC treatment Alecensa and immunotherapy Actemra

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links